Angiotensin II-induced over-activation of p47phox in fibroblasts from hypertensives: which role in the enhanced ERK1/2 responsiveness to angiotensin II?

J Hypertens. 2005 Apr;23(4):793-800. doi: 10.1097/01.hjh.0000163148.97459.9d.

Abstract

Background: Fibroblasts are involved in the remodeling of the heart and of the vasculature associated to arterial hypertension, and an abnormal extracellular signal-regulated kinase 1/2 (ERK1/2) activation by angiotensin II (Ang II) plays a pivotal role in this process. However, the intracellular pathways leading to cell hypertrophy and hyperplasia, as well as to collagen production, are still incompletely known.

Objective: To investigate the role of superoxide anion (O2) and of nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase in Ang II-stimulated ERK1/2 over-activation in fibroblasts from hypertensive patients.

Methods: O2 production was measured in skin fibroblasts from hypertensives (HT, n = 11) and from normotensive controls (NT, n = 10) by electron spin resonance technique. ERK1/2 phosphorylation and p47phox NAD(P)H oxidase subunit translocation were measured by western blot.

Results: Ang II (1 micromol/l) induced a larger p47phox subunit translocation and increased intracellular O2 production to a larger extent in HT in comparison to NT and this effect was blocked by apocynin, an inhibitor of the NAD(P)H oxidase. Ang II increased ERK1/2 phosphorylation more in HT than in NT. The Ang II-induced ERK1/2 phosphorylation was inhibited by apocynin in a dose-dependent manner in NT, but not in HT.

Conclusions: The chain of cellular events leading to increased ERK1/2 responsiveness to Ang II in hypertension include an exaggerated response of p47phox, NAD(P)H oxidase and O2, but it is partially resistant to apocynin. Therefore, NAD(P)H-dependent reactive oxygen species (ROS) production is not the only determinant of the exaggerated ERK1/2 responsiveness in fibroblasts of hypertensives (HT).

MeSH terms

  • Acetophenones / pharmacology
  • Adult
  • Angiotensin II / metabolism*
  • Angiotensin II / pharmacology
  • Antioxidants / pharmacology
  • Cell Membrane / enzymology
  • Cells, Cultured
  • Cytosol / enzymology
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Free Radicals / metabolism
  • Humans
  • Hypertension / metabolism*
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • Middle Aged
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • NADPH Oxidases
  • Phosphoproteins / metabolism*
  • Phosphorylation / drug effects
  • Reactive Oxygen Species / metabolism
  • Vasoconstrictor Agents / metabolism*
  • Vasoconstrictor Agents / pharmacology

Substances

  • Acetophenones
  • Antioxidants
  • Free Radicals
  • Phosphoproteins
  • Reactive Oxygen Species
  • Vasoconstrictor Agents
  • Angiotensin II
  • acetovanillone
  • NADPH Oxidases
  • neutrophil cytosolic factor 1
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3